Emergency Evacuation of a Bone Marrow Transplant Unit During Superstorm Sandy: This Was Not a Drill  by Thewes, Katherine et al.
Abstracts / Biol Blood Marrow Transplant 20 (2014) S297eS315S310marrow donors. These datawill be used to develop standards
of care for HSCT donors.
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The Importance of Skill Simulation and Its Role in the
Clinical Performance of the New Graduate BMT Nurse
Elizabeth Sito, Deborah Russell. Duke University Hospital,
Durham, North Carolina
Topic Signiﬁcance & Study Purpose/Background/Rationale:
The ﬁeld of Blood and Marrow Transplant has continued to
see a rise in the complexity and acuity of its patient popula-
tion. This is due to many factors including increases in patient
co-morbidities, post transplant complications and age. In
turn, the demand for safe and competent nursing care has
also increased as we strive to adapt our highly technological
care to the increased acuity. Research has shown that nursing
administrators believe that only 10% of new graduate nurses
are fully prepared to practice safely and effectively in the
hospital setting. New graduate nurses agree that they lack
conﬁdence and adequate skills for up to one year after grad-
uation (American Nurse Today, 2012). Evidence continues to
emerge supporting the use of simulation in the new graduate
nurse population as a tool to develop competencies and
clinical skills without harming patients (Galloway; OJIN,
2009). The increasing number of new graduate nurses
employed on our unit led us to explore the use of a simulation
facility to enhance conﬁdence and performance. New grad-
uate nurses hired within the last year were required to
participate. A pre-survey was conducted to measure level of
conﬁdence in practice and suggestions for skill simulation.
Suggestions included bladder irrigation for hemorrhagic
cystitis and polyoma virus, chest tube care following VATS
procedures for invasive fungal infections, and the use of
feeding tubes and enteral feeding for GVHD of the gut. Sta-
tions were developed with experienced staff members
providing the education.
Methods, Intervention, & Analysis: A pre-survey was con-
ducted to measure level of conﬁdence in practice and sug-
gestions for skill simulation. Suggestions included bladder
irrigation for hemorrhagic cystitis and polyoma virus, chest
tube care following VATS procedures for invasive fungal in-
fections, and the use of feeding tubes and enteral feeding for
GVHD of the gut. Stations were developed with experienced
staff members providing the education. Pre-skills day level of
conﬁdence averaged 3.1 and was measured on a 0-5 scale
with 0¼no conﬁdence and 5¼very conﬁdent/comfortable.
Findings & Interpretation: A debrieﬁng was held immedi-
ately following simulation and a post-survey was conducted
for feedback. Post simulation conﬁdence in practice
increased to 4.1 with 100% of participants recommending the
implementation of a yearly simulation skills day.
Discussion & Implications: The simulation environment
can provide a new graduate BMT nurse the opportunity to
increase their conﬁdence by enhancing decision making and
critical thinking skills.
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Standardization of IV Line and Pump Set-up to Improve
Clinical Outcomes in the Pediatric Blood and Marrow
Transplant Population
Theresa Steinke, Amanda Bombard, Rachel Amundsen.
University of Minnesota Amplatz Children’s Hospital,
Minneapolis, Minnesota
Topic Signiﬁcance & Study Purpose/Background/Rationale:
In August 2011, Fairview implemented the new smart pumpknown as the Baxter Sigma. The Pediatric Blood and Marrow
Transplant unit had been using the Omni pump, which was a
multi chamber pump capable of running four medications at
one time and had unique tubing. The Omni was able to run
syringe medications as well as medications in bags. The
implementation forced Nursing Practice Council (NPC) to
brainstorm a line and pump set-up that would provide an
equivalent process and workﬂow as the Omni. Unfortunately,
the Sigma can only run one bagmedication at a time and does
not have the capability to run a syringe medication. The new
set-up would require four Sigma pumps and two syringe
pumps to replace the one Omni. Finally, literature shows
standardization decreases errors.
Methods, Intervention, & Analysis: Two months prior to
implementation, NPC created a poster displaying a line set-
up that could accommodate the needs to administermultiple
IV medications simultaneously per patient into a double
lumen Hickman. In addition, NPC implemented a standard-
ized pump set-up to supplement the line set-up by creating
an “BMT Amplatz pole” order where every patient admitted
receives the pumps pre set-up from supply chain. Monthly
audits were done to check staff compliance and were re-
ported in a monthly unit newsletter. Yearly competencies are
used to evaluation assimilation of knowledge. A survey will
be conducted showing staff satisfaction.
Findings & Interpretation: Since implementation of the
standard line and pump set-up, our cyclosporine line
contamination has been zero, which is a decrease. Based on
ICAREs, Our medication errors related to infusion in the
wrong lumen and incompatibilities with other medications
has decreased from 12 in 2011, eight in 2012 and two in 2013
to date. We continue to have low BSI rates that are below the
nation average. From informal verbal surveys, we have heard
an increase in staff satisfaction related to productivity and
time management.
Discussion & Implications: Based on the results, we know
that the standardization has decreased medication errors
and increased staff satisfaction. We continue to evaluate the
effectiveness of the standardization set-up through verbal
feedback and future surveys. We continue to look for ways to
improve patient care and safety through standardization. In
the future, inpatient units that require many medications to
be given simultaneously could use a standardization set-up
to reduce medication errors and save nursing time.501
Emergency Evacuation of a Bone Marrow Transplant Unit
During Superstorm Sandy: This Was Not a Drill
Katherine Thewes, Michael Wuckovich, Roseanne DeRiso,
Stacey Blitzstein. NYU Langone Medical Center, New York,
New York
Topic Signiﬁcance & Study Purpose/Background/Rationale:
In October 2012, a hurricane was forecast for the East Coast.
Our Medical Center’s Hospital Incident Command System
(HICS), which facilitates operations in times of disaster, was
activated days in advance. Based on available data, the
decision was made to shelter in place. Our Bone Marrow
Transplant Unit (BMTU) held a census of four patients at the
time of the storm. The storm surge hit New York City leading
to an inﬂux of water into the streets, tunnels, and subway
lines, causing an unanticipated power outage to a large
portion of the city. Despite established backup systems which
were repeatedly tested, the storm exceeded all forecasts,
necessitating an evacuation. We will describe how nurses
led a collaborative approach to safely evacuate oncology
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(Figure 1).
Methods, Intervention, & Analysis: As the storm ap-
proached, interdisciplinary teams discharged many patients
hospital-wide, however the BMTU patients were deemed
unable to discharge. Private HEPA ﬁltered rooms were
blocked on the regular oncology unit as reserve in case the
BMTU became compromised. Nurses followed procedures for
blackout and computer down time; including the printing of
essential information from the electronic medical record
(EMR). Once power and communication systems failed,
nurses and other interdisciplinary team members safely
evacuated patients using med sled evacuation devices and
necessary equipment for monitoring and support down
sixteen ﬂights of dark stairwells to waiting ambulances. To
ensure safe transfer and a hand-off report to the receiving
hospital, nurses accompanied all BMTU patients. Hand-off
communication was also accomplished centrally from the
HICS using the previously printed EMR summaries (Figure 2).
Findings & Interpretation: A total of four patients, including
one autologous transplant patient and patients with
chemotherapy infusing, were transported to a neighboring
hospital without interruption of care. Staff relied on prior
disaster training, expert clinical judgment, and emotional
intelligence to accomplish this unprecedented task.
Discussion & Implications: Disaster training and drills are
vital to developing the skills needed during an emergency.
Nurses, as ﬁrst responders, lead in times of disaster. The ef-
forts of this team demonstrate what can be accomplished
when everyone is well trained and focused on the same goal,
patient safety.502
Does Plerixafor do the trick in mobilising Stem Cells?
Serpil Vieira, Diane Monroe. The London Clinic, London,
United Kingdom
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Plerixafor (MOZOBIL) is an antagonist of alpha-chemokine
receptor CXCR and one of the recent additions to the Hae-
matology discipline; it is used as a stem cell mobiliser. CXCR4
alpha-chemokine receptors are important in hematopoietic
stem cells homing to the bone marrow and in hematopoietic
stem cell quiescence. It is indicated in combination with
Granulocyte Colony Stimulating Factor (GCSF) for Peripheral
Blood Stem Cell (PBSC) collections in the Multiple Myeloma
(MM) and Lymphoma patient groups with a poor mobi-
lisation history.
Methods, Intervention, & Analysis: Method In our organi-
sation, data was collected prospectively. 35 patients (two
patients were included twice as they received Prelixafor on
two separate occasions) received Plerixafor for PBSC collec-
tion between May 2009 and September 2012. Patients met
the criteria prior to treatment, except three patients with low
platelet counts (white Blood Count> 2.5 x 109/L, Absolute
Neutrophil Count > 1.5 x 109/L, Platelet> 85 x 109/L, Serum
Creatinine < 1.5 mg/dL, Aspartate transaminase (AST),
Alanine Transaminase (ALT), Bilirubin < 2 x ULN with no
evidence of Hepatitis B and C. Patient demographic data is
shown in Table 1. Five patients had an underlying docu-
mented medical problem (cortochondritis, asthma, hyper-
tension and glaucoma).
Findings & Interpretation: Result: 25 of the patients were
diagnosed with MM and six with Non-Hodgkin’s Lymphoma
(NHL), two patients had Hodgkin’s Disease, one had Neuro-
blastoma and one Walderstorm’s Macroglobulinameia. All
patients received four consecutive days of GCSF 10 mg/kgprior to Plerixafor. Plerixafor was given 10 hours before the
PBSC collection and GCSF was repeated one hour prior to
PBSC collection on the morning. All patients received 0.24
mg/kg/day of Plerixafor. There were no side effects observed
in these episodes. 26 patients required single dose, 10 pa-
tients required a second dose, and only one patient received
three dose of Plerixafor.
For all cases, the target CD34+ count was 4 x 106 cells/kg
of recipient body weight. Two patients responded extremely
well with a CD34+ count of 21.79 x 106 cells/kg and 15.16
x106 cells/kg achieved. 13 patients achieved the target of 4
X106 cells/kg or above. However 22 patients failed to achieve
to reach target. 16 of these patients had adequate amounts of
CD34 count for an autologous transplant. Four patient failed
to mobilise with CD 34+ <2 X109cells/kg. Only six patient
had > CD 34+ <2 X109cells/kg one of this patient had no
CD34+ at all.
Discussion & Implications: Conclusion Plerixafor was used
at The London Clinic recently with mostly favourable out-
comes. According to this study Plerixafor has improved PBSC
outcomes with some exceptions. Plerixafor has deﬁnitely
made a positive difference in 40% of our patients and 83% had
enough cells for an autologus transplant. However, results
are inconclusive due to small patient numbers. Ongoing
studies with new patient experiences are needed. More than
one dose of Plerixafor may be required for heavily pre-
treated patients who are historically poor mobilisers of PBSC
collections.503
Do we give too much or too little?
Serpil Vieira, Diane Monroe. The London Clinic, London,
United Kingdom
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Introduction Over the last decade, information for cancer
patients has become increasingly more available. The very
nature of cancer requires patients to learn about their disease
in order to copewith the consequences of treatment and to be
involved in decision making processes. It is therefore vital to
provide enough information for patients and their relevant
others. People/patients vary in the amount of information
they require. Evidence suggests that some patients do not
want very much information about their diseases and treat-
ments. This study aims to explore howmuch information our
patient group wants to know and howmuch information our
team provides.
Methods, Intervention, & Analysis: Method A question-
naire was prepared to collect data on howmuch information
was given to patients on three different stages of their
treatment plans. These stages were: on admission, during
their inpatient stay and on discharge. A fourth section was
added, to investigate other information that patient felt
would be beneﬁcial. 112 questionnaires were given between
May 2010 and October 2012, outcome data is shown in Table
I. Stage Information provided on the following topics N, %
On admission
1. Side effects of therapy or chemotherapy 39 (34.8%)
2. Procedures (Bone Marrow Aspiration, Hickman Line
insertion etc) 35(31.2%)
3. Sexuality 11(9.8%)
4. Fertility 13(11.6%)
5. Results of diagnostic test 49(43.7%)
6. Follow up, appointments 39(34.8%)
7. Diet 23(20.5%) other 0(0%)
